Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Boston Scientific (BSX) Com Stk US $0.01

Sell:$44.68 Buy:$44.69 Change: $1.33 (3.06%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $1.33 (3.06%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $1.33 (3.06%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by businesses such Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. It operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy and Urology and Pelvic Health businesses. Rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.

Contact details

United States
+1 (508) 6834000

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$62.14 billion
Shares in issue:
1.42 billion
Health Care Equipment
New York Stock Exchange
United States
US dollar

Key personnel

  • Michael Mahoney
    Chairman of the Board, President, Chief Executive Officer
  • Daniel Brennan
    Chief Financial Officer, Executive Vice President
  • Arthur Butcher
    Executive Vice President and President, Asia Pacific
  • Joseph Fitzgerald
    Executive Vice President, President, Interventional Cardiology
  • Edward Mackey
    Executive Vice President - Global Operations
  • Ian Meredith
    Executive Vice President, Global Chief Medical Officer
  • Jeffrey Mirviss
    Executive Vice President and President - Peripheral Interventions
  • David Pierce
    Executive Vice President and President, MedSurg and President, Endoscopy
  • Eric Thepaut
    Executive Vice President and President - Europe, Middle East and Africa
  • Jodi Eddy
    Senior Vice President and Chief Information and Digital Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.